A carregar...

Global clinical response in Cushing’s syndrome patients treated with mifepristone

OBJECTIVE: Mifepristone, a glucocorticoid receptor antagonist, improves clinical status in patients with Cushing’s syndrome (CS). We examined the pattern, reliability and correlates of global clinical response (GCR) assessments during a 6-month clinical trial of mifepristone in CS. DESIGN: Post hoc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Endocrinol (Oxf)
Main Authors: Katznelson, Laurence, Loriaux, D Lynn, Feldman, David, Braunstein, Glenn D, Schteingart, David E, Gross, Coleman
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4255292/
https://ncbi.nlm.nih.gov/pubmed/24102404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen.12332
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!